GASTRIC AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

Clinical trials for GASTRIC AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new GASTRIC AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for GASTRIC AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for tough cancers: testing a Triple-Threat treatment

Disease control Completed

This study tested a new three-drug combination (afuresertib, sintilimab, and chemotherapy) for people with advanced solid tumors that had stopped responding to prior immunotherapy. The goal was to find a safe, effective dose and see if this combination could help control cancer g…

Matched conditions: GASTRIC AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: Laekna Limited • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

GASTRIC AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

Get alerted when new GASTRIC AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear

New hope for tough cancers: testing a Triple-Threat treatment